These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
302 related items for PubMed ID: 12495899
21. Treatment results of tonsillar lymphoma: a 10-year experience. Mohammadianpanah M, Omidvai S, Mosalei A, Ahmadloo N. Ann Hematol; 2005 Apr; 84(4):223-6. PubMed ID: 15042316 [Abstract] [Full Text] [Related]
29. A pilot study of epratuzumab and rituximab in combination with cyclophosphamide, doxorubicin, vincristine, and prednisone chemotherapy in patients with previously untreated, diffuse large B-cell lymphoma. Micallef IN, Kahl BS, Maurer MJ, Dogan A, Ansell SM, Colgan JP, Geyer S, Inwards DJ, White WL, Habermann TM. Cancer; 2006 Dec 15; 107(12):2826-32. PubMed ID: 17099879 [Abstract] [Full Text] [Related]
30. Improved therapeutic outcomes of DLBCL after introduction of rituximab in Korean patients. Park YH, Lee JJ, Ryu MH, Kim SY, Kim DH, Do YR, Lee KH, Oh SJ, Kim YK, Suh CW, Heo DS, Ryoo BY, Kim JK, Song HS, Lee WS, Kim HJ, Bang YJ, Yang SH, Sohn SK, Kang YK, Lymphoma Study Division of the Korean Cancer Study Group. Ann Hematol; 2006 Apr 15; 85(4):257-62. PubMed ID: 16416337 [Abstract] [Full Text] [Related]
31. Introduction of combined CHOP plus rituximab therapy dramatically improved outcome of diffuse large B-cell lymphoma in British Columbia. Sehn LH, Donaldson J, Chhanabhai M, Fitzgerald C, Gill K, Klasa R, MacPherson N, O'Reilly S, Spinelli JJ, Sutherland J, Wilson KS, Gascoyne RD, Connors JM. J Clin Oncol; 2005 Aug 01; 23(22):5027-33. PubMed ID: 15955905 [Abstract] [Full Text] [Related]
32. Role of hematopoietic stem cell transplantation for advanced-stage diffuse large cell B-cell lymphoma-B. Nademanee A, Forman SJ. Semin Hematol; 2006 Oct 01; 43(4):240-50. PubMed ID: 17027658 [Abstract] [Full Text] [Related]
36. Primary mediastinal large B-cell lymphoma with sclerosis in pediatric and adolescent patients: treatment and results from three therapeutic studies of the Berlin-Frankfurt-Münster Group. Seidemann K, Tiemann M, Lauterbach I, Mann G, Simonitsch I, Stankewitz K, Schrappe M, Zimmermann M, Niemeyer C, Parwaresch R, Riehm H, Reiter A, NHL Berlin-Frankfurt-Münster Group. J Clin Oncol; 2003 May 01; 21(9):1782-9. PubMed ID: 12721255 [Abstract] [Full Text] [Related]
38. Primary central nervous system lymphoma: the role of consolidation treatment after a complete response to high-dose methotrexate-based chemotherapy. Ekenel M, Iwamoto FM, Ben-Porat LS, Panageas KS, Yahalom J, DeAngelis LM, Abrey LE. Cancer; 2008 Sep 01; 113(5):1025-31. PubMed ID: 18618509 [Abstract] [Full Text] [Related]
39. [Comparison between R-CHOP regimen and CHOP regimen in treating naive diffuse large B-cell lymphoma in China--a multi-center randomized trail]. Lin TY, Zhang HY, Huang Y, Guan ZZ, Shen T, Shi YK, Zhu J, Ke XY, Wang HQ, Shen ZX, Yu SY, Liu T, Shi XL. Ai Zheng; 2005 Dec 01; 24(12):1421-6. PubMed ID: 16351785 [Abstract] [Full Text] [Related]
40. Rituximab in combination with CHOP chemotherapy for the treatment of diffuse large B cell lymphoma in Chinese patients. Li JM, Wang L, Shen Y, Xia ZG, Chen Y, Chen QS, Chen Y, Zeng XY, You JH, Qian Y, Shen ZX. Ann Hematol; 2007 Sep 01; 86(9):639-45. PubMed ID: 17572895 [Abstract] [Full Text] [Related] Page: [Previous] [Next] [New Search]